Drugs Made In America Acquisition II Corp.
Company Information
Industry
Blank Checks
SIC Code
6770
Entity Type
operating
SEC Category
Emerging growth company
Business Address
1 EAST BROWARD BOULEVARD, FORT LAUDERDALE, FL, 33301
Mailing Address
1 EAST BROWARD BOULEVARD, FORT LAUDERDALE, FL, 33301
Phone
954-870-3104
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 3, 2026 | View on SEC |
| 8-K Current report of material events | March 17, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 8-K Current report of material events | March 6, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 18, 2025 | View on SEC |
| 8-K Current report of material events | November 18, 2025 | View on SEC |
| 4 Insider stock transaction report | October 17, 2025 | View on SEC |
| 8-K Current report of material events | October 2, 2025 | View on SEC |
| 4 Insider stock transaction report | October 2, 2025 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | October 2, 2025 | View on SEC |
Material Events
8-K
Financial Distress
March 6, 2026
High Impact
- DMIA's sponsor made unauthorized withdrawals totaling $7.5 million from the company's working capital account.
- The company's Trust Account, holding approximately $507,841,957, remains intact and unaffected by the withdrawals.
Related Companies
Companies in the same industry (SIC: 6770)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.